|
Post by peppy on Nov 10, 2016 22:37:52 GMT -5
Cathode. Regards. A repost of the original API. Scientific and medical research listed.
|
|
|
Post by mango on Nov 10, 2016 22:56:36 GMT -5
Mannkind licensed the technology so it's up to RLS to do what they want. I don't believe the licensing came with dictating what they can and can't do No one makes deals without discussing what will be done first. 😉 MannKind knows exactly what they are making but said they cannot disclose anything other than what they did. — Under the terms of the agreement, MannKind will perform ***initial*** formulation studies and will work with Receptor to develop inhaled formulations of certain undisclosed compounds. MannKind will also transfer manufacturing technology to the licensee, who will be responsible for manufacturing and commercialization activities. The parties will collaborate on the clinical development of investigational products, with Receptor being responsible for all development costs. MannKind will be eligible to receive development and commercialization milestones of up to $102.25 million as well as mid-single to low double-digit royalties on net sales of product. —See these words: Under the term of the agreement —Seems to me, MannKind is making the INITIAL formulation studies. So, how is RLS just gonna go run off and do whatever they want again? —Yep. investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=951141
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 11, 2016 5:07:00 GMT -5
Mannkind licensed the technology so it's up to RLS to do what they want. I don't believe the licensing came with dictating what they can and can't do While I do not know the terms of the deal I am guessing it does set guidelines and parameters for what they can and cannot do. For example, otherwise what is to stop them from competing with MannKind if they could? Also am sure MannKind does not want them presenting a conflict for other possible deals using TS. ofcourse they would restrict - what Mannkind would have in their pipeline. I am thinking thats the only 1 restriction Before licensing, RLS have had to disclose what they planned to do with technosphere - plant based products as per their trademark.
|
|
|
Post by peppy on Nov 13, 2016 7:08:34 GMT -5
Note dates: this is just our reminder 5/29/16
the USPTO has refused - pending clarifications for the "RECEPTOR LIFE SCIENCES" and "RECEPTOR" marks on the following grounds
TRADEMARK ACT §2(d) REFUSAL – LIKELIHOOD OF CONFUSION WITH
PRIOR REGISTERED MARKS/LIMITED TO CLASSES 5 AND 42
TRADEMARK ACT §2(e)(1) REFUSAL – MARK IS MERELY DESCRIPTIVE
IDENTIFICATION OF GOODS REQUIRES AMENDMENT/CLASS 5 ONLY Pharmaceutical preparations for human use for {indicate intended use, e.g., the treatment of skin disorders, use in chemotherapy, treating diabetes}; inhalers sold pre-filled with pharmaceutical preparations, namely, {indicate specific pharmaceutical preparations} ; plant extracts for pharmaceutical purposes
RLS need to reply within 6 months . tsdr.uspto.gov/documentviewer?caseId=sn86913299&docId=OOA20160529080207#docIndex=0&page=1
tsdr.uspto.gov/documentviewer?caseId=sn86898208&docId=OOA20160529080028#docIndex=0&page=1
the original api
|
|
|
Post by cgiscgis on Nov 14, 2016 5:46:31 GMT -5
Now their website is completely down. Will be interesting to see by end of the month who is behind this company. Also quite interesting that Amphastar website is down as well ... CHINA!?
|
|
|
Post by patten1962 on Nov 14, 2016 6:57:15 GMT -5
While I do not know the terms of the deal I am guessing it does set guidelines and parameters for what they can and cannot do.  For example, otherwise what is to stop them from competing with MannKind if they could?  Also am sure MannKind does not want them presenting a conflict for other possible deals using TS. ofcourse they would restrict - what Mannkind would have in their pipeline. I am thinking thats the only 1 restriction Before licensing, RLS have had to disclose what they planned to do with technosphere - plant based products as per their trademark. Mr iam2, you told me you know who they are, why don't you just ask them? Also, you seem to be the only one on the board that knows them so please share with everyone. And thank you again.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 14, 2016 7:22:42 GMT -5
ofcourse they would restrict - what Mannkind would have in their pipeline. I am thinking thats the only 1 restriction Before licensing, RLS have had to disclose what they planned to do with technosphere - plant based products as per their trademark. Mr iam2, you told me you know who they are, why don't you just ask them? Also, you seem to be the only one on the board that knows them so please share with everyone. And thank you again. I posted the team info in other thread , but cant see to find now as that post was deleted..here I have no need to talk to them and find . If you want to confirm your speculations, you can. I dont have any. So I just stay put.
|
|
|
Post by peppy on Nov 14, 2016 7:48:29 GMT -5
I recognize the above and have a copy of where the information came from. That does seem to be the listed RLS team.
Pep
If I post it, I will be struck dead.
|
|
|
Post by patten1962 on Nov 14, 2016 8:10:30 GMT -5
I recognize the above and have a copy of where the information came from. That does seem to be the listed RLS team.
Pep
If I post it, I will be struck dead. We just don't know if RLS is a independent entity or they are part of a bigger parent company. I know I am probably stating the obvious. Just trying to be clear on the point that I am making.
|
|
|
Post by peppy on Nov 14, 2016 8:35:33 GMT -5
I recognize the above and have a copy of where the information came from. That does seem to be the listed RLS team.
Pep
If I post it, I will be struck dead. We just don't know if RLS is a independent entity or they are part of a bigger parent company. I know I am probably stating the obvious. Just trying to be clear on the point that I am making. This is what I think I know. There is so much money in marijuana, the time has come. Regarding Medical Use, you know ad nauseam I think the best way to legitimize marijuana medical in dose controlled is a high cannabinoid CBD charolettes web type plant extract. I would love to see a study on an epilepsy cure. Then arthritis. The work has been done for years, studies done in Jerusalem have found the cannabinoids that ease arthritis. The market would be huge and legitimate.
Regarding entity, the potential entity is huge. States rights. weehaw
|
|
|
Post by mnholdem on Nov 14, 2016 8:52:18 GMT -5
peppy,
You're acting too cheerfully for a member of the Nasty Women's Club, aren't you?
|
|
|
Post by sportsrancho on Nov 14, 2016 9:44:55 GMT -5
Now their website is completely down. Will be interesting to see by end of the month who is behind this company. Also quite interesting that Amphastar website is down as well ... CHINA!? The Amphastar website is not down.
|
|
|
Post by mango on Nov 14, 2016 9:50:58 GMT -5
Now their website is completely down. Will be interesting to see by end of the month who is behind this company. Also quite interesting that Amphastar website is down as well ... CHINA!? RLS is not down. The tree is still standing On the other hand, the Teuza fund domain is 404 and Israel domain remains username/password protected. Follow the money.
|
|
|
Post by mango on Nov 14, 2016 10:21:55 GMT -5
Mr iam2, you told me you know who they are, why don't you just ask them? Also, you seem to be the only one on the board that knows them so please share with everyone. And thank you again. I posted the team info in other thread , but cant see to find now as that post was deleted..here I have no need to talk to them and find . If you want to confirm your speculations, you can. I dont have any. So I just stay put. Your description of Arthur Rubinfeld is incorrect. He is still currently the Chief Creative Officer for Starbucks;President of Global Development. Your description says former President. The fact that the Arthur Rubinfeld description is incorrect and fails to give an accurate current description just adds to the list I have that supports the doc being fake. But hey, we will find out soon enough! www.fastcompany.com/user/arthur-rubinfelden.m.wikipedia.org/wiki/Arthur_Rubinfeldphx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjYyNzE4fENoaWxkSUQ9LTF8VHlwZT0z&t=1
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 14, 2016 10:27:56 GMT -5
perhaps you need to remind Starbucks of their chief creative office and ask their team to update the leadership page news.starbucks.com/leadership
|
|